To compare the efficacy and safety of frovatriptan and almotriptan in women with menstrually related migraine (ICHD-II criteria) enrolled in a multicentre, randomized, double-blind, crossover study. Conclusions Frovatriptan was as effective as almotriptan in the immediate treatment of menstrually related migraine attacks. However, it showed a more favorable sustained effect, as shown by a lower rate of migraine recurrence.

Efficacy of frovatriptan versus almotriptan for acute treatment of menstrual migraine: analysis of a double-blind, randomized, crossover, multicentre Italian, comparative study / M., Bartolini; M. A., Giamberardino; C., Lisotto; P., Martelletti; D., Moscato; B., Panascia; L., Savi; Pini, Luigi Alberto; G., Sances; P., Santoro; G., Zanchin; S., Omboni; M. D., Ferrari; B., Fierro; F., Brighina. - In: THE JOURNAL OF HEADACHE AND PAIN. - ISSN 1129-2369. - STAMPA. - 13:(2012), pp. S48-S48. (Intervento presentato al convegno XXVI Nation Congress of the Italian Society for the Study of Headaches. Pharmacological therapies and beyond tenutosi a Modena nel 26-28 October 2012).

Efficacy of frovatriptan versus almotriptan for acute treatment of menstrual migraine: analysis of a double-blind, randomized, crossover, multicentre Italian, comparative study

PINI, Luigi Alberto;
2012

Abstract

To compare the efficacy and safety of frovatriptan and almotriptan in women with menstrually related migraine (ICHD-II criteria) enrolled in a multicentre, randomized, double-blind, crossover study. Conclusions Frovatriptan was as effective as almotriptan in the immediate treatment of menstrually related migraine attacks. However, it showed a more favorable sustained effect, as shown by a lower rate of migraine recurrence.
2012
13
S48
S48
M., Bartolini; M. A., Giamberardino; C., Lisotto; P., Martelletti; D., Moscato; B., Panascia; L., Savi; Pini, Luigi Alberto; G., Sances; P., Santoro; ...espandi
Efficacy of frovatriptan versus almotriptan for acute treatment of menstrual migraine: analysis of a double-blind, randomized, crossover, multicentre Italian, comparative study / M., Bartolini; M. A., Giamberardino; C., Lisotto; P., Martelletti; D., Moscato; B., Panascia; L., Savi; Pini, Luigi Alberto; G., Sances; P., Santoro; G., Zanchin; S., Omboni; M. D., Ferrari; B., Fierro; F., Brighina. - In: THE JOURNAL OF HEADACHE AND PAIN. - ISSN 1129-2369. - STAMPA. - 13:(2012), pp. S48-S48. (Intervento presentato al convegno XXVI Nation Congress of the Italian Society for the Study of Headaches. Pharmacological therapies and beyond tenutosi a Modena nel 26-28 October 2012).
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/851710
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact